Characterization of the resistance mechanisms of HL60 leukemia cell derivatives to Apo2L/TRAIL.

被引：0
|
作者：
Cheng, JR [1 ]
Hyladder, BL [1 ]
Baer, MR [1 ]
Repasky, EA [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.3412.3412
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3412
引用
收藏
页码：931A / 931A
页数：1
相关论文
共 50 条
  • [31] Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells
    Lippa, Mara S.
    Strockbine, Laura D.
    Le, Tiep T.
    Branstetter, Daniel G.
    Strathdee, Craig A.
    Holland, Pamela M.
    APOPTOSIS, 2007, 12 (08) : 1465 - 1478
  • [32] Triggering cell death: The crystal structure of Apo2L/TRAIL in a complex with death receptor 5
    Hymowitz, SG
    Christinger, HW
    Fuh, G
    Ultsch, M
    O'Connell, M
    Kelley, RF
    Ashkenazi, A
    de Vos, AM
    MOLECULAR CELL, 1999, 4 (04) : 563 - 571
  • [33] Molecular basis of autophagy-mediated resistance to radiation and Apo2L/TRAIL therapy of prostate cancer
    Singh, Kamini
    Mazumder, Suparna
    Almasan, Alex
    CANCER RESEARCH, 2010, 70
  • [34] Resistance to Apo2 Ligand (Apo2L)/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines (Retraction of vol 79, pg 1367, 2005)
    Matsuda, Takehiro
    Almasan, Alex
    Tomita, Mariko
    Uchihara, Jun-Nosuke
    Masuda, Masato
    Ohshiro, Kazuiku
    Takasu, Nobuyuki
    Yagita, Hideo
    Ohta, Takao
    Mori, Naoki
    JOURNAL OF VIROLOGY, 2011, 85 (03) : 1416 - 1416
  • [35] Monocyte-Macrophage Differentiation Suppresses the Expression of Proapoptotic Receptors to Apo2L/TRAIL and Increases Resistance to TRAIL-Induced Apoptosis
    Evstratova Y.V.
    Kobyakova M.I.
    Novikova V.V.
    Senotov A.S.
    Akatov V.S.
    Fadeev R.S.
    Biophysics, 2019, 64 (5) : 729 - 731
  • [36] Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL
    Bae, S. I.
    Cheriyath, V.
    Jacobs, B. S.
    Reu, F. J.
    Borden, E. C.
    ONCOGENE, 2008, 27 (04) : 490 - 498
  • [37] TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
    Mitsiades, CS
    Treon, SP
    Mitsiades, N
    Shima, Y
    Richardson, P
    Schlossman, R
    Hideshima, T
    Anderson, KC
    BLOOD, 2001, 98 (03) : 795 - 804
  • [38] Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL
    S I Bae
    V Cheriyath
    B S Jacobs
    F J Reu
    E C Borden
    Oncogene, 2008, 27 : 490 - 498
  • [39] Induction of apoptosis in the human promyelocytic leukemia cell line HL60 by falconensone A and its derivatives, new polyenes
    Takahashi, N
    Kubo, Y
    Iwahori, A
    Kawai, K
    Fukui, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (06) : 748 - 754
  • [40] Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosis in myeloma cell lines
    Liu, Q
    El-Deiry, WS
    Gazitt, Y
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (08) : 962 - 970
12345